Description

• • Cartalax (25mg) is a synthetic peptide complex intended for laboratory research use only and has been studied for its potential involvement in cartilage and connective tissue biology within experimental models.
  • Preclinical studies have investigated Cartalax for its influence on gene expression related to chondrocyte activity and extracellular matrix components such as collagen and elastin.
  • This peptide has been evaluated in non-clinical settings to examine its role in cellular responses associated with structural protein synthesis and tissue integrity.
  • Cartalax is commonly used in research focused on tendon, ligament, and cartilage-related pathways under laboratory-controlled stress or mechanically induced models.
  • Cartalax is commonly used in research focused on tendon, ligament, and cartilage-related pathways under laboratory-controlled stress or mechanically induced models.